William J. Boyle
Corporate Officer/Principal chez BIOATLA, INC.
Profil
William J.
Boyle was the founder of AnaptysBio, Inc. which was founded in 2005, where he held the title of Chief Scientific Officer from 2010 to 2013.
Dr. Boyle is also the founder of Aeolian Therapeutics, Inc. Currently, Dr. Boyle holds the position of Head-Senior Research at BioAtla, Inc. since 2013 and is the owner of Peninsula Biopharma LLC.
Dr. Boyle's former positions include Director-Discovery Research at Amgen, Inc., Director at Alethia Biotherapeutics, Inc., Chief Scientific Officer at Auxeris Therapeutics, Inc., and Vice President-Biology at Protein Pathways, Inc. Dr. Boyle received a doctorate degree from David Geffen School of Medicine.
Postes actifs de William J. Boyle
| Sociétés | Poste | Début |
|---|---|---|
| BIOATLA, INC. | Corporate Officer/Principal | 01/05/2013 |
| Aeolian Therapeutics, Inc. | Founder | - |
| Peninsula Biopharma LLC | Corporate Officer/Principal | - |
Anciens postes connus de William J. Boyle
| Sociétés | Poste | Fin |
|---|---|---|
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Director/Board Member | - |
Auxeris Therapeutics, Inc.
 Auxeris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Auxeris Therapeutics, Inc. manufactures drugs for osteoporosis, bone metastasis and other bone diseases. The company was founded in 2002 and is located in St. Louis, MO | Chief Tech/Sci/R&D Officer | - |
| Protein Pathways, Inc. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
| ANAPTYSBIO, INC. | Founder | - |
Formation de William J. Boyle
| David Geffen School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ANAPTYSBIO, INC. | Health Technology |
| BIOATLA, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Auxeris Therapeutics, Inc.
Auxeris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Auxeris Therapeutics, Inc. manufactures drugs for osteoporosis, bone metastasis and other bone diseases. The company was founded in 2002 and is located in St. Louis, MO | Health Technology |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Health Technology |
| Aeolian Therapeutics, Inc. | |
| Peninsula Biopharma LLC | |
| Protein Pathways, Inc. |
